GO:0141003 histone H2AX kinase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0141003 (histone H2AX kinase activity) describes the catalytic transfer of a phosphate group to the histone variant H2AX, a key chromatin modification in the DNA damage response.
• ATM is the predominant kinase responsible for H2AX phosphorylation after DNA damage, including after heating, while other kinases such as VRK1, PKM2, and TOPK also contribute under specific conditions.
• H2AX phosphorylation is a hallmark of DNA double-strand breaks and is required for the recruitment of DNA repair factors, but it can be dispensable for certain viral replications.
• Dysregulation of H2AX kinase activity is implicated in cancer radioresistance, telomere-initiated senescence, and melanoma survival, making it a target for therapeutic intervention.
• Studying this activity requires tools such as phospho-specific antibodies, kinase inhibitors, and CRISPR-based gene editing to dissect kinase-substrate relationships.
• EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression cell models and library screening to accelerate research on H2AX kinases and their roles in disease.
Description
Histone H2AX kinase activity (GO:0141003) is a molecular function defined as the catalysis of phosphate group transfer to the histone variant H2AX. This modification, known as gamma-H2AX, is one of the earliest cellular responses to DNA double-strand breaks and is critical for the assembly of DNA repair machinery at damage sites. The kinase activity is primarily attributed to ATM, but other kinases such as VRK1, PKM2, and TOPK can also phosphorylate H2AX under specific conditions. Understanding this activity is essential for researchers studying genome stability, cancer therapy resistance, and cellular senescence. The phosphorylation of H2AX serves as a platform for recruiting repair proteins and checkpoint factors, thereby influencing cell cycle arrest and survival decisions. Given its central role in DNA damage signaling, histone H2AX kinase activity is a focal point for developing targeted cancer therapies and for interpreting responses to genotoxic agents.
histone H2AX kinase activity At A Glance
| GO ID | GO:0141003 |
|---|---|
| GO term | histone H2AX kinase activity |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Catalysis of phosphate transfer to histone variant H2AX |
| Major kinases | ATM, VRK1, PKM2, TOPK |
| Substrate | Histone H2AX (serine 139) |
| Biological context | DNA damage response, telomere-initiated senescence, apoptosis regulation |
| Disease relevance | Cancer radioresistance, melanoma, herpes simplex virus replication |
What Is GO:0141003?
GO:0141003, histone H2AX kinase activity, is defined by QuickGO as the catalysis of the transfer of a phosphate group to a histone variant H2AX. In other words, it is the enzymatic activity that adds a phosphate to the H2AX histone protein, typically on serine 139, generating gamma-H2AX. This activity is a molecular function that initiates a cascade of DNA damage response events, including the recruitment of repair factors and activation of cell cycle checkpoints.
Why Is histone H2AX kinase activity Important in Cell Biology?
Histone H2AX kinase activity is crucial because it marks sites of DNA double-strand breaks and orchestrates the recruitment of repair proteins, thereby maintaining genomic integrity. This activity influences cell fate decisions such as survival, apoptosis, and senescence, and its dysregulation is linked to cancer progression and therapy resistance. Moreover, it plays a role in viral replication and telomere maintenance, making it a broad target for biomedical research.
• Initiates DNA damage signaling by phosphorylating H2AX to form gamma-H2AX foci.
• Recruits DNA repair factors such as MDC1 and 53BP1 to damage sites.
• Regulates cell cycle checkpoints through Chk1 and Chk2 pathways.
• Contributes to telomere-initiated senescence and aging.
• Modulates apoptosis in melanoma cells via TOPK-mediated H2AX phosphorylation.
• Influences radioresistance in cancer cells through AMPK-WIP1 signaling.
• Can be dispensable for herpes simplex virus replication, highlighting context specificity.
• Is downregulated by Tip60/NuA4 acetyltransferase activity after DNA damage.
• Serves as a biomarker for DNA double-strand breaks in preclinical and clinical studies.
• Target for radiosensitizers and chemotherapeutics that inhibit ATM or related kinases.
What Happens During histone H2AX kinase activity?
DNA damage recognition and kinase activation
In simple terms: When DNA breaks, sensor proteins activate kinases that will modify H2AX.
Upon DNA double-strand breaks, the MRN complex recruits and activates ATM, the predominant H2AX kinase. Other kinases such as VRK1 and PKM2 can also be activated in response to specific stresses, including ionizing radiation and arsenite exposure. This activation leads to the phosphorylation of H2AX at serine 139, creating gamma-H2AX.
Phosphorylation of H2AX and formation of gamma-H2AX foci
In simple terms: The kinase adds a phosphate to H2AX, which then clusters into visible foci at damage sites.
Activated kinases transfer a phosphate group to histone H2AX, generating gamma-H2AX. This modification spreads over megabase regions around the break and forms discrete nuclear foci that can be detected by immunofluorescence. The phosphorylation is rapid and reversible, with phosphatases such as WIP1 contributing to its turnover.
Recruitment of DNA repair and checkpoint proteins
In simple terms: Gamma-H2AX acts as a landing pad for proteins that fix DNA and pause the cell cycle.
Gamma-H2AX directly binds to MDC1, which amplifies ATM signaling and recruits downstream factors like 53BP1 and BRCA1. This leads to activation of checkpoint kinases Chk1 and Chk2, causing cell cycle arrest to allow repair. The repair process can proceed via non-homologous end joining or homologous recombination, depending on the cell cycle phase.
Resolution and dephosphorylation
In simple terms: After repair, the phosphate is removed to reset the signal.
Once DNA repair is complete, gamma-H2AX is dephosphorylated by phosphatases including WIP1, and the foci dissolve. Additionally, the Tip60/NuA4 acetyltransferase complex promotes H2AX downregulation through acetylation, facilitating the removal of gamma-H2AX. This resolution is essential to prevent persistent DNA damage signaling that could lead to senescence or apoptosis.
Key Genes Involved in GO:0141003 histone H2AX kinase activity
The following genes encode kinases, phosphatases, and interacting proteins that directly regulate or are regulated by histone H2AX kinase activity.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ATM | Primary kinase phosphorylating H2AX at serine 139 | Central to DNA damage response; target for radiosensitizers |
| VRK1 | Chromatin kinase that phosphorylates H2AX in response to DNA damage | Modulates repair efficiency; depleted in Olaparib-treated cells |
| PKM2 | Protein kinase that phosphorylates H2AX under arsenite stress | Prevents apoptosis in melanoma; potential therapeutic target |
| TOPK | Lymphokine-activated killer T-cell-originated protein kinase | Phosphorylates H2AX to prevent arsenite-induced apoptosis |
| WIP1 | Phosphatase that dephosphorylates gamma-H2AX | Regulates DNA repair and radioresistance; phosphorylated by AMPK |
| AMPK | Kinase that phosphorylates WIP1 to promote DNA repair | Links metabolism to DNA repair; promotes radioresistance |
| TIP60 | Histone acetyltransferase that downregulates H2AX phosphorylation | Required for H2AX dephosphorylation after DNA damage |
| RVB1 | Component of Tip60/NuA4 complex | Required for Tip60 acetyltransferase activity and H2AX downregulation |
| CHK1 | Checkpoint kinase mediating cell cycle arrest | Downstream of H2AX signaling; target for cancer therapy |
| CHK2 | Checkpoint kinase mediating cell cycle arrest | Downstream of H2AX signaling; target for cancer therapy |
| MAPKAPK2 | Mitogen-activated protein kinase-activated protein kinase 2 | Mediates DNA damage-induced cell cycle arrest |
| H2AX | Histone variant substrate of the kinase activity | Forms gamma-H2AX foci; biomarker of DNA damage |
| MDC1 | Mediator of DNA damage checkpoint 1 | Binds gamma-H2AX and amplifies signaling |
| 53BP1 | p53-binding protein 1 | Recruited to gamma-H2AX foci; promotes repair |
| BRCA1 | Breast cancer type 1 susceptibility protein | Recruited to damage sites; involved in homologous recombination |
| Herpes simplex virus proteins | Viral factors that may modulate H2AX phosphorylation | H2AX phosphorylation is dispensable for HSV replication |
How Is histone H2AX kinase activity Regulated?
Histone H2AX kinase activity is tightly regulated at multiple levels. ATM activation is controlled by the MRN complex and autophosphorylation. Phosphatases such as WIP1 dephosphorylate gamma-H2AX to terminate signaling, and WIP1 itself is regulated by AMPK in response to metabolic stress. Additionally, the Tip60/NuA4 acetyltransferase complex promotes H2AX dephosphorylation through acetylation, providing a feedback mechanism. Kinases like VRK1 and PKM2 can also phosphorylate H2AX under specific conditions, indicating context-dependent regulation.
histone H2AX kinase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ATM | Cancer radioresistance, ataxia-telangiectasia | ATM knockout cell lines, patient-derived xenografts |
| VRK1 | Cancer therapy resistance, Olaparib response | VRK1 knockout or knockdown cells treated with Olaparib and radiation |
| TOPK | Melanoma survival and apoptosis resistance | TOPK overexpression or knockout in RPMI7951 melanoma cells |
| WIP1 | Cancer radioresistance, DNA repair | WIP1 mutant knock-in or knockout cells with AMPK activation |
| TIP60 | DNA damage response, cancer | TIP60 knockout or acetyltransferase-deficient mutants |
Cancer and radioresistance
Histone H2AX kinase activity is frequently upregulated in cancer cells and contributes to resistance to ionizing radiation and chemotherapy. AMPK-mediated phosphorylation of WIP1 promotes DNA repair and radioresistance, making this pathway a target for sensitizing tumors. VRK1 depletion impairs the cooperative DNA damage response triggered by Olaparib and radiation, suggesting that VRK1 inhibitors could enhance PARP inhibitor efficacy. TOPK-mediated H2AX phosphorylation prevents arsenite-induced apoptosis in melanoma cells, supporting TOPK as a therapeutic target.
Telomere-initiated senescence and aging
Dysfunctional telomeres activate a DNA damage checkpoint response that involves H2AX phosphorylation, leading to cellular senescence. This process is a hallmark of aging and age-related diseases, and modulating H2AX kinase activity could influence senescence onset.
Viral replication
H2AX phosphorylation and DNA damage kinase activity are dispensable for herpes simplex virus replication, indicating that some viruses can replicate without activating this pathway. This finding has implications for antiviral strategies that target DNA damage responses.
From histone H2AX kinase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does ATM kinase activity solely account for H2AX phosphorylation after DNA damage? | ATM knockout and point-mutation (kinase-dead) cell lines |
| How does VRK1 contribute to H2AX phosphorylation in combination with PARP inhibition? | VRK1 knockout cells treated with Olaparib and ionizing radiation |
| Can TOPK-mediated H2AX phosphorylation be targeted to induce apoptosis in melanoma? | TOPK overexpression and knockout in melanoma cell lines |
| What is the role of WIP1 dephosphorylation in radioresistance? | WIP1 knock-in (phospho-mutant) and knockout cells under AMPK activation |
| How does Tip60/NuA4 regulate H2AX dephosphorylation? | TIP60 or RVB1 knockout cells with DNA damage induction |
| Is H2AX phosphorylation required for herpes simplex virus replication? | H2AX knockout or phospho-deficient knock-in cells infected with HSV |
How to Study the histone H2AX kinase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Immunofluorescence | Gamma-H2AX foci number and intensity | Detection of DNA double-strand breaks after radiation |
| Western blot | Total gamma-H2AX protein levels | Kinase activation after drug treatment |
| In vitro kinase assay | Direct phosphorylation of H2AX by purified kinases | Identification of specific H2AX kinases |
| CRISPR knockout | Loss-of-function effects on H2AX phosphorylation | Determining essential kinases |
| Phosphoproteomics | Global phosphorylation sites and dynamics | Mapping signaling networks |
| Comet assay | DNA strand breaks | Confirming DNA damage induction |
| Flow cytometry | Cell cycle arrest and apoptosis | Linking H2AX phosphorylation to cell fate |
| qRT-PCR | mRNA expression of H2AX kinases | Transcriptional regulation studies |
Immunofluorescence and gamma-H2AX foci quantification
Immunofluorescence using phospho-specific antibodies against gamma-H2AX is the gold standard for detecting histone H2AX kinase activity in situ. This method visualizes discrete nuclear foci at DNA damage sites and allows quantification of foci number and intensity. It is widely used to assess DNA damage response activation after radiation or drug treatment.
Western blotting and kinase assays
Western blotting with anti-gamma-H2AX antibodies measures global H2AX phosphorylation levels after various stimuli. In vitro kinase assays using recombinant H2AX and immunoprecipitated kinases can directly measure catalytic activity and identify specific kinases responsible.
CRISPR-based gene editing and knockout screens
CRISPR knockout of candidate kinases (e.g., ATM, VRK1, TOPK) followed by gamma-H2AX detection can determine which kinases are required for H2AX phosphorylation under specific conditions. Library screening with CRISPR can identify novel regulators of H2AX kinase activity.
Proteomics and phosphoproteomics
Mass spectrometry-based phosphoproteomics can map phosphorylation sites on H2AX and identify kinase-substrate relationships. This approach is useful for discovering novel kinases and phosphatases that regulate H2AX phosphorylation.
How CRISPR Can Be Used to Study GO:0141003 histone H2AX kinase activity
Knockout
CRISPR knockout of kinases such as ATM, VRK1, or TOPK in cell lines can abolish H2AX phosphorylation at specific sites, allowing researchers to attribute kinase activity to specific enzymes. For example, ATM knockout cells show dramatically reduced gamma-H2AX after heating, confirming ATM as the predominant kinase.
Point Mutation
Introducing kinase-dead point mutations (e.g., ATM D2870A) via CRISPR knock-in can distinguish catalytic activity from scaffolding functions. Similarly, phospho-deficient H2AX mutants (S139A) prevent gamma-H2AX formation and downstream repair factor recruitment.
Knock-in
Knock-in of tagged H2AX (e.g., GFP-H2AX) enables live-cell imaging of H2AX phosphorylation dynamics and foci formation. Knock-in of phospho-mimetic H2AX (S139D) can mimic constitutive phosphorylation and assess downstream effects.
Overexpression
Overexpression of kinases like TOPK or PKM2 can enhance H2AX phosphorylation and protect cells from apoptosis, as shown in melanoma cells. Overexpression of phosphatases like WIP1 can reduce gamma-H2AX levels and affect radioresistance.
How EDITGENE Supports histone H2AX kinase activity Research
Researchers studying histone H2AX kinase activity-related genes often need to determine whether a candidate gene is causally involved in DNA damage signaling, repair, or disease progression. EDITGENE provides a comprehensive suite of CRISPR-based services to create precisely engineered cell models that enable such causal inferences.
Contact EDITGENE today to design your custom CRISPR model for histone H2AX kinase activity research.
Frequently Asked Questions About histone H2AX kinase activity
What is histone H2AX kinase activity?
Histone H2AX kinase activity (GO:0141003) is the enzymatic transfer of a phosphate group to the histone variant H2AX, primarily at serine 139, forming gamma-H2AX, a key marker of DNA double-strand breaks.
What genes are involved in histone H2AX kinase activity?
Major genes include ATM, VRK1, PKM2, TOPK, and WIP1, which encode kinases or phosphatases that regulate H2AX phosphorylation.
Which kinase is the predominant one for H2AX phosphorylation?
ATM is the predominant kinase involved in H2AX phosphorylation after DNA damage, including after heating.
How is histone H2AX kinase activity measured?
It is commonly measured by immunofluorescence for gamma-H2AX foci, Western blotting, or in vitro kinase assays.
What diseases are associated with histone H2AX kinase activity?
It is implicated in cancer radioresistance, melanoma survival, telomere-initiated senescence, and viral replication.
Can histone H2AX kinase activity be targeted for cancer therapy?
Yes, inhibitors of ATM, VRK1, or TOPK are being explored to sensitize cancer cells to radiation and chemotherapy.
What is the role of VRK1 in H2AX phosphorylation?
VRK1 is a chromatin kinase that phosphorylates H2AX and its depletion impairs the cooperative DNA damage response to Olaparib and radiation.
How does TOPK regulate H2AX phosphorylation?
TOPK phosphorylates H2AX to prevent arsenite-induced apoptosis in melanoma cells.
What is the relationship between AMPK and H2AX phosphorylation?
AMPK phosphorylates WIP1, which promotes DNA repair and radioresistance, indirectly affecting H2AX phosphorylation status.
Is H2AX phosphorylation required for herpes simplex virus replication?
No, H2AX phosphorylation and DNA damage kinase activity are dispensable for herpes simplex virus replication.
Conclusion
Histone H2AX kinase activity (GO:0141003) is a central molecular function in the DNA damage response, with broad implications for cancer, aging, and viral infection. The interplay between kinases such as ATM, VRK1, and TOPK and phosphatases like WIP1 determines cell fate after genotoxic stress. Understanding this activity requires robust experimental models, and CRISPR-based approaches are invaluable for dissecting causal roles. EDITGENE offers comprehensive services to support such research, from knockout and knock-in models to library screening and bioinformatics.
References
- 1. Botting C et al.. 2016. H2AX phosphorylation and DNA damage kinase activity are dispensable for herpes simplex virus replication.. Virol J 13:15 PMID: 26817608
- 2. Campillo-Marcos I et al.. 2019. Olaparib and ionizing radiation trigger a cooperative DNA-damage repair response that is impaired by depletion of the VRK1 chromatin kinase.. J Exp Clin Cancer Res 38(1):203 PMID: 31101118
- 3. Xiao Z et al.. 2006. Differential roles of checkpoint kinase 1, checkpoint kinase 2, and mitogen-activated protein kinase-activated protein kinase 2 in mediating DNA damage-induced cell cycle arrest: implications for cancer therapy.. Mol Cancer Ther 5(8):1935-43 PMID: 16928813
- 4. d'Adda di Fagagna F et al.. 2003. A DNA damage checkpoint response in telomere-initiated senescence.. Nature 426(6963):194-8 PMID: 14608368
- 5. Zykova TA et al.. 2006. Lymphokine-activated killer T-cell-originated protein kinase phosphorylation of histone H2AX prevents arsenite-induced apoptosis in RPMI7951 melanoma cells.. Clin Cancer Res 12(23):6884-93 PMID: 17145805
- 6. Lu M et al.. 2025. AMPK phosphorylates WIP1 to promote DNA repair and radioresistance in cancer cells.. Cell Death Dis 16(1):864 PMID: 41315219
- 7. Takahashi A et al.. 2010. ATM is the predominant kinase involved in the phosphorylation of histone H2AX after heating.. J Radiat Res 51(4):417-22 PMID: 20448412
- 8. Jha S et al.. 2008. Human Rvb1/Tip49 is required for the histone acetyltransferase activity of Tip60/NuA4 and for the downregulation of phosphorylation on H2AX after DNA damage.. Mol Cell Biol 28(8):2690-700 PMID: 18285460
